Corino Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.corinorx.com
A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-08-16
- Last Posted Date
- 2019-01-31
- Lead Sponsor
- Corino Therapeutics, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT03633591
- Locations
- 🇬🇧
Quotient Sciences, Ruddington, Nottingham, United Kingdom
© Copyright 2024. All Rights Reserved by MedPath